{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T10:13:56Z","timestamp":1793182436468,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","jshoulderelbow.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Shoulder and Elbow Surgery"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jse.2024.09.012","type":"journal-article","created":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T13:38:02Z","timestamp":1731159482000},"page":"1152-1157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Glucagon-like peptide-1 receptor agonist use is associated with increased risk of perioperative complication and readmission following shoulder arthroplasty"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8233-3436","authenticated-orcid":false,"given":"Jad J.","family":"Lawand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Tansey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0438-6532","authenticated-orcid":false,"given":"Abdullah","family":"Ghali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0605-6254","authenticated-orcid":false,"given":"Cooper","family":"Tye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8442-9768","authenticated-orcid":false,"given":"Ashraf","family":"Hantouly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad Y.","family":"Fares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam Z.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7272-5922","authenticated-orcid":false,"given":"Jeremy S.","family":"Somerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3845-7220","authenticated-orcid":false,"given":"Joseph A.","family":"Abboud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jse.2024.09.012_bib1","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jcot.2019.03.003","article-title":"Does diabetes affect functional outcomes after shoulder arthroplasty?","volume":"10","author":"Alsubheen","year":"2019","journal-title":"J Clin Orthop Trauma"},{"key":"10.1016\/j.jse.2024.09.012_bib2","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/1753-0407.13469","article-title":"Should glucagon-like peptide-1 receptor agonist treatment be withheld in preoperative management?","volume":"15","author":"Bloomgarden","year":"2023","journal-title":"J Diabetes"},{"key":"10.1016\/j.jse.2024.09.012_bib3","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1001\/jama.2019.19365","article-title":"Prevalence of diabetes by race and ethnicity in the United States, 2011-2016","volume":"322","author":"Cheng","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jse.2024.09.012_bib4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jse.2022.07.028","article-title":"Effect of obesity on short- and long-term complications of shoulder arthroplasty","volume":"32","author":"Cogan","year":"2023","journal-title":"J Shoulder Elbow Surg"},{"key":"10.1016\/j.jse.2024.09.012_bib5","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1053\/j.sart.2023.06.011","article-title":"Total shoulder vs. hip and knee arthroplasty: an analysis of perioperative outcomes","volume":"33","author":"Dean","year":"2023","journal-title":"Semin Arthroplasty"},{"key":"10.1016\/j.jse.2024.09.012_bib6","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","article-title":"The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes","volume":"368","author":"Drucker","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jse.2024.09.012_bib7","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1016\/j.jseint.2023.06.025","article-title":"Risk factors for postoperative transfusion in diabetic patients following total shoulder arthroplasty","volume":"7","author":"Fassler","year":"2023","journal-title":"JSES Int"},{"key":"10.1016\/j.jse.2024.09.012_bib8","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.2106\/JBJS.RVW.O.00044","article-title":"The effect of diabetes mellitus on total joint arthroplasty outcomes","volume":"4","author":"Hogan","year":"2016","journal-title":"JBJS Rev"},{"key":"10.1016\/j.jse.2024.09.012_bib9","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1056\/NEJMoa1901118","article-title":"Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"381","author":"Husain","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jse.2024.09.012_bib10","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/dbi16-0014","article-title":"Glucagon-like peptide 1 receptor activation and platelet function: beyond glycemic control","volume":"65","author":"Jia","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.jse.2024.09.012_bib11","author":"Joshi"},{"key":"10.1016\/j.jse.2024.09.012_bib12","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.2106\/JBJS.18.01136","article-title":"Preoperative weight loss for morbidly obese patients undergoing total knee arthroplasty: determining the necessary amount","volume":"101","author":"Keeney","year":"2019","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.jse.2024.09.012_bib13","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.arth.2023.12.023","article-title":"Semaglutide use prior to total hip arthroplasty results in fewer postoperative prosthetic joint infections and readmissions","volume":"39","author":"Magruder","year":"2024","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.jse.2024.09.012_bib14","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1016\/j.arth.2023.05.071","article-title":"Does semaglutide use decrease complications and costs following total knee arthroplasty?","volume":"38","author":"Magruder","year":"2023","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.jse.2024.09.012_bib15","article-title":"Discontinuation and reinitiation of SGLT-2 inhibitors and GLP-1R agonists in patients with type 2 diabetes: a nationwide study from 2013 to 2021","volume":"29","author":"Malik","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.jse.2024.09.012_bib16","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.2106\/JBJS.H.00116","article-title":"The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty","volume":"91","author":"Marchant","year":"2009","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.jse.2024.09.012_bib17","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jse.2024.09.012_bib18","doi-asserted-by":"crossref","DOI":"10.1093\/jamiaopen\/ooad035","article-title":"A global federated real-world data and analytics platform for research","volume":"6","author":"Palchuk","year":"2023","journal-title":"JAMIA Open"},{"key":"10.1016\/j.jse.2024.09.012_bib19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411892","article-title":"A randomized, controlled trial of 3.0 mg of liraglutide in weight management","volume":"373","author":"Pi-Sunyer","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jse.2024.09.012_bib20","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jse.2014.01.046","article-title":"Diabetes as a risk factor for poorer early postoperative outcomes after shoulder arthroplasty","volume":"23","author":"Ponce","year":"2014","journal-title":"J Shoulder Elbow Surg"},{"key":"10.1016\/j.jse.2024.09.012_bib21","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S2213-8587(14)70004-X","article-title":"Combating the dual burden: therapeutic targeting of common pathways in obesity and type 2 diabetes","volume":"2","author":"Scheen","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jse.2024.09.012_bib22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/jim-2021-001952","article-title":"Wegovy (semaglutide): a new weight loss drug for chronic weight management","volume":"70","author":"Singh","year":"2022","journal-title":"J Investig Med"},{"key":"10.1016\/j.jse.2024.09.012_bib23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S2213-8587(17)30013-X","article-title":"Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial","volume":"5","author":"Sorli","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jse.2024.09.012_bib24","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/ajhp\/zxad086","article-title":"National trends in prescription drug expenditures and projections for 2023","volume":"80","author":"Tichy","year":"2023","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jse.2024.09.012_bib25","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1161\/CIRCULATIONAHA.118.034516","article-title":"Effects of liraglutide on cardiovascular outcomes in patients with type 2 diabetes mellitus with or without history of myocardial infarction or stroke","volume":"138","author":"Verma","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jse.2024.09.012_bib26","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/ije\/dyz273","article-title":"Has the prevalence of overweight, obesity and central obesity levelled off in the United States? Trends, patterns, disparities, and future projections for the obesity epidemic","volume":"49","author":"Wang","year":"2020","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jse.2024.09.012_bib27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.japh.2023.10.002","article-title":"Trends in glucagon-like peptide 1 receptor agonist use, 2014 to 2022","volume":"64","author":"Watanabe","year":"2024","journal-title":"J Am Pharm Assoc (2003)"},{"key":"10.1016\/j.jse.2024.09.012_bib28","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"}],"container-title":["Journal of Shoulder and Elbow Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1058274624007985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1058274624007985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T02:33:25Z","timestamp":1744425205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1058274624007985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1058274624007985"],"URL":"https:\/\/doi.org\/10.1016\/j.jse.2024.09.012","relation":{},"ISSN":["1058-2746"],"issn-type":[{"value":"1058-2746","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucagon-like peptide-1 receptor agonist use is associated with increased risk of perioperative complication and readmission following shoulder arthroplasty","name":"articletitle","label":"Article Title"},{"value":"Journal of Shoulder and Elbow Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jse.2024.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Journal of Shoulder and Elbow Surgery Board of Trustees. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}